Mepivacaína Normon (Mepivacaine Hydrochloride)

Mepivacaine is a local anesthetic used to provide reversible loss of sensation in various surgical and diagnostic procedures.

• Dental procedures: provides local anesthesia for extractions, restorations and periodontal surgery.
• Minor surgical procedures: enables anesthesia for skin suturing, biopsy and minor excisions.
• Diagnostic arthroscopy: facilitates intra‑articular anesthesia for joint examinations and minor interventions.

• Mepivacaine reversibly blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of action potentials. By stabilizing the neuronal membrane, it inhibits nerve impulse transmission in the targeted area, resulting in a temporary loss of sensation without affecting consciousness.

Mepivacaine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Burning or stinging at the injection site.
• Mild dizziness or light‑headedness.
• Nausea or a metallic taste.
• Headache.
• Transient hypotension.
• Localized swelling or erythema.

Serious or Rare Side Effects

• Allergic reactions such as rash, urticaria or anaphylaxis.
• Central nervous system toxicity including seizures.
• Cardiac arrhythmias or conduction disturbances.
• Methemoglobinemia.
• Persistent numbness or paresthesia.
• Respiratory depression.

When using Mepivacaína Normon, consider the following safety measures.

• Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics.
• Cardiac disease: use caution in patients with conduction abnormalities or ischemic heart disease.
• Intravascular injection: avoid accidental intravascular administration to reduce systemic toxicity.
• CNS monitoring: observe for signs of central nervous system excitation or depression.
• Hepatic impairment: consider dose adjustment in patients with significant liver dysfunction.
• Store at room temperature: keep in the original container, protect from moisture and light.

Mepivacaine can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Class I antiarrhythmics (e.g., quinidine, procainamide): may enhance cardiotoxicity.
• Beta‑blockers (e.g., propranolol): increase risk of bradycardia and hypotension.
• Tricyclic antidepressants (e.g., amitriptyline): potentiate central nervous system toxicity.

Moderate Interactions (Monitor Closely)

• Epinephrine-containing solutions: may prolong anesthetic effect and increase cardiovascular strain.
• Other local anesthetics: cumulative toxicity risk when combined.
• Hepatic enzyme inhibitors (e.g., cimetidine): may raise plasma levels of mepivacaine.